Natixis’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.7K Buy
2,100
+67
+3% +$3.18K ﹤0.01% 997
2026
Q1
$105K Buy
+2,033
New +$142K ﹤0.01% 945
2025
Q4
Sell
-12,088
Closed -$897K 1214
2025
Q3
$897K Buy
+12,088
New +$1.22M ﹤0.01% 690
2024
Q1
Sell
-6,809
Closed -$1.39M 1119
2023
Q4
$1.39M Sell
6,809
-1,617
-19% -$262K 0.01% 470
2023
Q3
$1.67M Sell
8,426
-1,341
-14% -$338K 0.01% 423
2023
Q2
$3.17M Sell
9,767
-53
-0.5% -$15.1K 0.03% 351
2023
Q1
$2.3M Sell
9,820
-6,721
-41% -$1.7M 0.02% 397
2022
Q4
$4.17M Buy
16,541
+5,800
+54% +$1.24M 0.02% 405
2022
Q3
$1.97M Sell
10,741
-462
-4% -$92.8K 0.01% 610
2022
Q2
$2.04M Buy
11,203
+1,586
+16% +$316K 0.01% 659
2022
Q1
$2.47M Buy
+9,617
New +$2.2M 0.01% 706
2021
Q4
Sell
-10,726
Closed -$2.5M 1289
2021
Q3
$2.5M Sell
10,726
-785
-7% -$164K 0.01% 683
2021
Q2
$2.23M Sell
11,511
-191
-2% -$37.9K 0.01% 506
2021
Q1
$2.42M Sell
11,702
-458
-4% -$97.3K 0.01% 657
2020
Q4
$2.29M Sell
12,160
-457
-4% -$74.7K 0.01% 664
2020
Q3
$1.63M Buy
+12,617
New +$1.39M 0.01% 456

Other funds holding INSP

Natixis's INSP Position: Q2 2026 in Review

Natixis increased its Inspire Medical Systems (INSP) stake by 3.3% in Q2 2026, buying an estimated $3.18K and bringing the position to 2,100 shares worth $93.7K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Natixis first reported a position in INSP in Q3 2020 and has held it in 16 quarters since. The position peaked at $4.17M in Q4 2022. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Natixis held 2,100 shares of Inspire Medical Systems worth $93.7K as of Q2 2026.
  • Natixis bought 67 Inspire Medical Systems shares in Q2 2026, an estimated $3.18K.
  • Inspire Medical Systems made up ﹤0.01% of Natixis's portfolio in Q2 2026, its #997 holding.
  • Natixis first reported a position in Inspire Medical Systems in Q3 2020 and has held it in 16 quarters since.
  • Natixis's Inspire Medical Systems position peaked at $4.17M in Q4 2022.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.